VF
CNSP icon

Virtu Financial’s CNS Pharmaceuticals CNSP Stock Holding History

Virtu Financial’s Portfolio CNSP Stock Details CNSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,946
Closed -$19K – 1552
2025
Q2 		$19K Buy
+1,946
New +$24.4K ﹤0.01% 1256
2025
Q1 		– Sell
-271
Closed -$20K – 1453
2024
Q4 		$20K Buy
271
+66
+32% +$4.69K ﹤0.01% 1297
2024
Q3 		$16K Buy
+205
New +$58.8K ﹤0.01% 1146
2024
Q2 		– Sell
-3
Closed -$34K – 1388
2024
Q1 		$34K Buy
+3
New +$43.6K ﹤0.01% 1080
2023
Q4 		– Hold
0
– – – 1339
2023
Q2 		– Hold
0
– -$11K – 1590
2023
Q1 		– Hold
0
– – – 1333
2022
Q4 		– Hold
0
– -$23K – 1691
2022
Q3 		– Hold
0
– – – 1365
2022
Q2 		– Hold
0
– – – 1125
2022
Q1 		– Hold
0
– – – 1194
2021
Q4 		– Hold
0
– -$33K – 1775
2021
Q3 		– Hold
0
– – – 1331
2021
Q2 		– Hold
0
– – – 1358
2021
Q1 		– Hold
0
– – – 1326

Other funds holding CNSP

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Barrett & Company Providence, Rhode Island $357M AUM 22.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Virtu Financial's CNSP Position: Q3 2025 in Review

Virtu Financial sold out of CNS Pharmaceuticals (CNSP) in Q3 2025, closing a stake of 1,946 shares — an estimated $19K sold.

Virtu Financial first reported a position in CNSP in Q1 2024 and held it in 4 quarters. The position peaked at $34K in Q1 2024. 8 funds tracked by Wall St. Rank hold CNSP as of Q3 2025.

  • Virtu Financial reported no remaining CNS Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Virtu Financial sold 1,946 CNS Pharmaceuticals shares in Q3 2025, an estimated $19K.
  • Virtu Financial first reported a position in CNS Pharmaceuticals in Q1 2024 and held it in 4 quarters.
  • Virtu Financial's CNS Pharmaceuticals position peaked at $34K in Q1 2024.
  • 8 funds tracked by Wall St. Rank held CNS Pharmaceuticals as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.